From January 1, 2022 to March 31, 2022, the company has repurchased 49,868 shares, representing 0.42% for KRW 4,745.81 million. With this, the company has completed the repurchase of 160,533 shares, representing 1.35% for KRW 19,650.63 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,02,300 KRW | -2.85% | +2.30% | -21.85% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.85% | 949M | |
+15.26% | 42.02B | |
+21.16% | 21.66B | |
+17.26% | 15.09B | |
+16.48% | 14.21B | |
+46.44% | 12.37B | |
-0.05% | 6.79B | |
-9.88% | 6.59B | |
+14.13% | 5.56B | |
+4.17% | 4.64B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.